Virtual Medicinal Product (VMP) - Poractant alfa 120mg/1.5ml endotracheopulmonary suspension vials

Navigation

Name Details

Name Start Date End Date
Name Current Name Poractant alfa 120mg/1.5ml endotracheopulmonary suspension vials Start Date 17-09-2004 End Date
Previous Name Previous Name Poractant alfa 120mg/1.5ml endotracheopulmonary instillation suspension vials Start Date 23-08-2004 End Date 16-09-2004
Abbreviated Name Abbreviated Name Poractant alfa 120mg/1.5ml endotracheopulmonary susp vials Start Date 13-03-2009
Previous Abbreviated Name Poractant alfa 120mg/1.5ml endotracheopulmonary suspn vials Previous Start Date 17-09-2004 Previous End Date 12-03-2009

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1.5
UDFS UOM
ml
Unit Dose UOM
vial

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Endotracheopulmonary
Form
Suspension for endotracheopulmonary instillation
Ontology Form/Route
suspension.endotracheopulmonary
Name Basis
BAN - British Approved Name

Codes

ATC Code
n/a
BNF Codes
  • BNF code 03050200
SNOMED Codes
Code Start Date End Date
35898611000001107 17-10-2018
320910003 23-08-2004 16-10-2018

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Poractant alfa Based on Ingredient Substance 80 mg 1 ml

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
1 vial